Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

Autor: Hudecek, J., Voorwerk, L., van Seijen, M., Nederlof, I., de Maaker, M., van den Berg, J., van de Vijver, K. K., Sikorska, K., Adams, S., Demaria, S., Viale, G., Nielsen, T. O., Badve, S. S., Michiels, S., Symmans, W. F., Sotiriou, C., Rimm, D. L., Hewitt, S. M., Denkert, C., Loibl, S., Loi, S., Bartlett, J. M. S., Pruneri, G., Dillon, D. A., Cheang, M. C. U., Tutt, A., Hall, J. A., Kos, Z., Salgado, R., Kok, M., Horlings, H. M., Hyytiainen, A., Hida, A. I., Thompson, A., Lefevre, A., Lazar, A. J., Gown, A., Lo, A., Sapino, A., Madabhushi, A., Moreira, A., Richardson, A., Vingiani, A., Beck, A. H., Bellizzi, A. M., Guerrero, A., Grigoriadis, A., Ehinger, A., Garrido-Castro, A., Vincent-Salomon, A., Laenkholm, A. -V., Sharma, A., Cimino-Mathews, A., Srinivasan, A., Acs, B., Singh, B., Calhoun, B., Haibe-Kans, B., Solomon, B., Thapa, B., Nelson, B. H., Gallas, B. D., Castaneda, C., Ballesteros-Merino, C., Criscitiello, C., Boeckx, C., Colpaert, C., Quinn, C., Chennubhotla, C. S., Swanton, C., Solinas, C., Hiley, C., Drubay, D., Bethmann, D., Moore, D. A., Larsimont, D., Sabanathan, D., Peeters, D., Zardavas, D., Hoflmayer, D., Johnson, D. B., Thompson, E. A., Brogi, E., Perez, E., Elgabry, E. A., Stovgaard, E. S., Blackley, E. F., Roblin, E., Reisenbichler, E., Bellolio, E., Balslev, E., Chmielik, E., Gaire, F., Andre, F., F. -I., Lu, Azmoudeh-Ardalan, F., Rojo, F., Gruosso, T., Ciompi, F., Peale, F., Hirsch, F. R., Klauschen, F., Penault-Llorca, F., Acosta Haab, G., Farshid, G., van den Eynden, G., Curigliano, G., Floris, G., Broeckx, G., Gonzalez-Ericsson, Koeppen, H., Haynes, H. R., Mcarthur, H., Joensuu, H., Olofsson, H., Lien, H. -C., Chen, I. -C., Cree, I., Frahm, I., Brcic, I., Chan, J., Ziai, J., Brock, J., Wesseling, J., Giltnane, J., Kerner, J. K., Thagaard, J., Braybrooke, J. P., van der Laak, J. A. W. M., Lemonnier, J., Zha, J., Ribeiro, J., Lennerz, J. K., Carter, J. M., Saltz, J., Hartman, J., Hainfellner, J., Quesne, J. L., Juco, J. W., Reis-Filho, J., Sanchez, J., Sparano, J., Cucherousset, J., Araya, J. C., Adam, J., Balko, J. M., Saeger, K., Siziopikou, K., Willard-Gallo, K., Weber, K., Pogue-Geile, K. L., Steele, K. E., Emancipator, K., Abduljabbar, K., El Bairi, K., Blenman, K. R. M., Allison, K. H., Korski, K., Pusztai, L., Comerma, L., Buisseret, L., Cooper, L. A. D., Shi, L., Kooreman, L. F. S., Molinero, L., Estrada, M. V., Lacroix-Triki, M., Al Bakir, M., Sebastian, M. M., van de Vijver, M., Balancin, M. L., Dieci, M. V., Mathieu, M. -C., Rebelatto, M. C., Piccart, M., Hanna, M. G., Goetz, M. P., Preusser, M., Khojasteh, M., Sanders, M. E., Regan, M. M., Barnes, M., Christie, M., Misialek, M., Ignatiadis, M., van Bockstal, M., Castillo, M., Amgad, M., Harbeck, N., Tung, N., Laudus, N., Sirtaine, N., Burchardi, N., Ternes, N., Radosevic-Robin, N., Gluz, O., Grimm, O., Nuciforo, P., Jank, P., Gonzalez-Ericsson, P., Kirtani, P., Jelinic, P., Watson, P. H., Savas, P., Francis, P. A., Russell, P. A., Singh, R., Kim, R. S., Pierce, R. H., Hills, R., Leon-Ferre, R., de Wind, R., Shui, R., De Clercq, S., Leung, S., Tabbarah, S., Souza, S. C., O'Toole, S., Swain, S., Dudgeon, S., Willis, S., Ely, S., Kim, S. -R., Bedri, S., Irshad, S., Liu, S. -W., Goel, S., Hendry, S., Bianchi, S., Braganca, S., Paik, S., Wienert, S., Fox, S. B., Luen, S. J., Naber, S., Schnitt, S. J., Sua, L. F., Lakhani, S. R., Fineberg, S., Soler, T., Gevaert, T., D'Alfonso, T., John, T., Sugie, T., Kurkure, U., Bossuyt, V., Manem, V., Camara, V. P., Tong, W., Chen, W., Yang, W., Tran, W. T., Wang, Y., Yuan, Y., Allory, Y., Husain, Z., Bago-Horvath, Z.

Publikováno v: NPJ breast cancer, 6
npj Breast Cancer
npj Breast Cancer, Nature, 2020, 6 (1), pp.15. ⟨10.1038/s41523-020-0155-1⟩
NPJ Breast Cancer
npj Breast Cancer, Vol 6, Iss 1, Pp 1-8 (2020)
2020, ' Application of a risk-management framework for integration of stromal Tumor Infiltrating Lymphocytes in clinical trials ', NPJ Breast Cancer . https://doi.org/10.1038/s41523-020-0155-1
NPJ BREAST CANCER
npj Breast Cancer, 2020, 6 (1), pp.15. ⟨10.1038/s41523-020-0155-1⟩

Stromal tumor-infiltrating lymphocytes (sTILs) are a potential predictive biomarker for immunotherapy response in metastatic triple-negative breast cancer (TNBC). To incorporate sTILs into clinical trials and diagnostics, reliable assessment is essen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cc0eed7935fac67e7046bd597e941f6
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/317463

Morphological and Molecular Characterization of Intramedullary Astrocytomas

Autor: Lebrun, L., Asensio, B. Melendez, Blanchard, O., De Neve, N., De Clercq, S., Balsat, C., Dewitte, O., Baleriaux, D., Brotchi, J., Bruneau, M., Decaestecker, C., D'haene, N., Salmon, I.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3848::73b3fcac2265584f1828cc6c152bcf4b
https://biblio.vub.ac.be/vubir/morphological-and-molecular-characterization-of-intramedullary-astrocytomas(0b61f563-e85d-4a9d-980e-ff09f4bc58d2).html

71P NTRK gene fusions in bilio-pancreatic cancers

Autor: Demols, A., Perez-Casanova, L., Rocq, L., Charry, M., De Nève, N., Verrellen, A., Ramadhan, A., Van Campenhout, C., De Clercq, S., Maris, C., Closset, J., Lucidi, V., Salmon, I., D'Haene, N.

Publikováno v: In Annals of Oncology September 2020 31 Supplement 4:S268-S268

Waarheen met de digitale algemene vergadering? (Dutch/Flemish)

Autor: de Clercq, S., Koster, H.

Publikováno v: TvOB, Tijdschrift voor Vennootschapsrecht, Rechtspersonenrecht en Ondernemingsbestuur; Dec2020, p230-239, 10p

Nature Cell Biology

Autor: Sotiropoulou PA, Candi A, Mascrxe9 G, De Clercq S, Kass Youseff K, Lapouge G, Dahl E, Semeraro C, Denecker G, Marine JC, Blanpain C

Publikováno v: Bcl2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA damage.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=erc_________::dc9a4352882c5e50a0f5bd899e69cae7